AQP4+MOG+

Katharina Messias1, Renata Moreto2, Kelvin Ferrari Corniani2

  • 1Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil; Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

まとめ

抗アクアポリン4抗体 (AQP4+) 視神経炎 (ON) は,ミエリンオリゴデンドロシートグリコタンパク質 (MOG+) よりも重度の視力および機能障害を引き起こす. AQP4+ONは相関する構造的損失を示し,MOG+ONは補償メカニズムを示唆しています.